New COVID-19 Resources Available
Please see the latest visual abstracts on COVID-19-related topics in English, Spanish, Portuguese, and French. Kidney International paper examines therapeutic options for patients with kidney disease.
An Announcement from Kidney International Concerning the Covid19 Infection
The Editorial Team of Kidney International would like to reassure our readership that we will continue to bring you high quality information throughout the COVID-19 pandemic to help all of us deal with the crisis and provide high quality care to our patients. We have a mechanism in place to rapidly review and arrive...
ISN President, Vivek Jha, takes the lead on the “Novel Coronavirus 2019 Epidemic and Kidneys”
Novel coronavirus disease (COVID-19) is a newly discovered contagious disease caused by SARS-CoV-2 virus, primarily manifesting as an acute respiratory illness with interstitial and alveolar pneumonia, but can affect multiple organs such as kidney, heart, digestive tract, blood and nervous system. The rapidly spreading outbreak which first emerged in Wuhan, Hubei Province in China...
Milestones in Nephrology: Treatment of Glomerular Diseases – Pioneering Clinical Trials
Celebrating ISN’s 60th anniversary, Kidney International’s “Milestones in Nephrology” series continues with a review of some of the original articles it has published on the treatment of glomerular disease, publications that helped make significant changes in patient management: Shorter term corticosteroids are equally effective as longer term in primary nephrotic syndrome in children (Yoshikawa N, Nakanishi K, Sako...
Milestones in Nephrology: Systemic autoimmune diseases and the kidney
To celebrate ISNs 60th anniversary, Kidney International’s “Milestones in Nephrology” series continues with a review of some of the original articles it has published on the effects of systemic autoimmune diseases on the kidney. These articles have characterized the pathology and clinical course of these diseases and enabled the nephrology community to make informed decisions in...
Pathophysiology of the glomerulus: KI tells the story
To celebrate ISN’s 60th anniversary throughout 2020, Kidney International’s “Milestones in Nephrology” series launches with a review of the development in understanding of the pathophysiology of the glomerulus, highlighting several original articles published in KI: The glomerular signature in patients with hematuria (Kenneth F. Fairley and Douglas F. Birch, 1982); The permselectivity of the glomerular capillary wall (Ramsay L.S....
August in KI: Take time out for reading
The editors of Kidney International (KI) would like to share a selection of articles from the August edition of the publication. Articles focus on a broad range of topics from renal pathology practice globally, the genomic landscape of CAKUT, identifying geospatial “hotspots” of glomerular diseases, the disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of...
ISN-ACT Global Trials Focus: CKD, dialysis and hypertension
This month, the first series of clinical trials curated by the ISN-Advancing Clinical Trials (ISN-ACT) team will get us thinking about nephrology research and encourage more discussion about chronic kidney disease, dialysis and hypertension: from PD catheter exit site care, the effectiveness of Roxadustat, to the initial treatment of hypertension in Sub-Saharan Africans and...
June in KI: Take time out for reading
This month, we have lots of new educational material for you to delve into. From new in-depth reviews in Kidney International (KI) to June's KI editor’s picks. Big science and big data in nephrology Over the next few months, Kidney International (KI) will feature in-depth reviews on big science, artificial intelligence, and machine learning. This review, the first in this series, provides...
KI publishes paper on ESKD and Universal Health Coverage
Kidney International (KI) has published a paper, as a Supplement to its journal, focusing on increasing patient access to integrated end-stage kidney disease care (ESKD) and how this fits in with Universal Health Coverage . Authored by David Harris et al., the paper is entitled 'Increasing access to integrated ESKD care as part of Universal...
2018 KDIGO hepatitis C in CKD guideline now available!
An executive summary of the 2018 KDIGO hepatitis C in CKD guideline: Welcoming advances in evaluation and management is now available in Kidney International. Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy and in those with a...
KI article shows the doubling incidence, prevalence and mortality of CKD
September's issue of Kidney international (KI) will feature an important article from Ziyad Al-Aly and colleagues, which uses Global Burden of Disease (GBD) data to show, in just one generation since 1990, an almost doubling of the incidence, prevalence and mortality of chronic kidney disease (CKD), and a more than 60% increase in disability-adjusted...
KI and KI Supplements impact factor 2017 now released
The 2017 impact factors have now been published. Find out more about how our publications have been rated! Kidney International’s (KI) 2017 Impact Factor has increased to 8.429 (a small increase over the 2016 IF of 8.395). Kidney International Supplements 2017 Impact Factor is 3.357 (a decrease from the 2016 IF of 5.593). KI ranks now...
Check out the CKD Summit papers in The Lancet and KI Supplements
Following March's second Global Kidney Health Summit in the United Arab Emirates, the outputs from this meeting are currently being written for publication. In the meantime, here is what came out the first Global Kidney Health Summit held in Canada in 2016. During the first ISN Global Kidney Health Summit, a selected group of 85 international key...
Meet Kidney International’s latest Editor in Chief
We sat down with Pierre Ronco to discover what lies ahead for one of nephrology’s leading journals and hear about his plans to respond to the challenges of publishing and education within the field. What do you enjoy the most about heading such a high-ranking journal? Pierre Ronco: ‘It is a privilege and a huge responsibility. Fortunately,...
KI launches ‘Brief reports’
The purpose of the Brief Report format is to publish concise but complete reports that present high-quality findings of exceptional interest, novelty, and broad significance for the readers of Kidney International. Manuscript considered as a potential Brief Report by the Editors will be sent to referees with a request of rapid review. If the manuscript...
Congratulations to KI Reports!
We are excited to announce that Kidney International (KI) Reports has now been fully accepted and is live in PubMed Central (PMC). PMC indexed back to Volume 1, Issue 1 and there are 177 article records at present. We will feed new articles as they are published directly to PMC for indexing. KI Reports article records can...
Introducing the ISN Ethical Dialysis Taskforce
As part of the end-stage kidney disease (ESKD) focus, the ISN Ethical Dialysis Taskforce will publish reviews and position statements on ethical dialysis over the next few years. We already developed a first series of papers on ethical dialysis published in The Lancet. This will be relevant to emerging and developed countries. As a global society with...
Challenges of pediatric acute kidney injury in low- and middle-income countries
Acute kidney injury (AKI) is an increasingly significant yet underdiagnosed problem in pediatric care. In this latest Lancet update, colleagues from the International Pediatric Nephrology Association delve into international efforts to address this inequity, and what’s required from the World Health Organization and nephrology community to fulfil the 0by25 mission of zero preventable deaths from...
KI Reports: Heat stress and kidney health
One of this month’s most downloaded reports from Kidney International (KI) Reports is contributed by Fabiana Nerbass, winner of the ISN-H4KH New Investigator grant. This publication was made possible with valuable support from the ISN-H4KH New Investigator grant in partnership with Danone Nutricia. Fabiana Nerbass was awarded the funding in 2015. Her research on “Occupational Heat Stress...